Skip to content
10-K

Annual Report

NEXUS BIOPHARMA INC

0001213900-17-007185

← back to feed
Filed
Jul 5, 2017 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2017 · Jul 5, 2017 64.3M sh
Cash And Equivalents FY 2017 · Feb 28, 2017 $77
Cash And Equivalents FY 2017 · Feb 29, 2016 $9.93K
Cash And Equivalents FY 2017 · Feb 28, 2015 $22.05K
Current Liabilities FY 2017 · Feb 28, 2017 $1.42M
Current Liabilities FY 2017 · Feb 29, 2016 $735.61K
Total Liabilities FY 2017 · Feb 28, 2017 $1.46M
Total Liabilities FY 2017 · Feb 29, 2016 $776.72K
Current Assets FY 2017 · Feb 28, 2017 $1.08K
Current Assets FY 2017 · Feb 29, 2016 $9.93K
Total Assets FY 2017 · Feb 28, 2017 $9.53K
Total Assets FY 2017 · Feb 29, 2016 $9.93K
Sga Expense FY 2017 · Feb 28, 2017 $623.68K
Sga Expense FY 2017 · Feb 29, 2016 $917.96K
Rd Expense FY 2017 · Feb 28, 2017 $31.4K
Rd Expense FY 2017 · Feb 29, 2016 $233.84K
Net Income FY 2017 · Feb 28, 2017 −$686.1K
Net Income FY 2017 · Feb 29, 2016 −$1.15M